Advertisement
News
Advertisement

FDA News & Notes - Week of June 13, 2011

Mon, 06/13/2011 - 12:35pm
Bio-Medicine.Org

SILVER SPRING, Md., June 13, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of June 13, 2011.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Meetings, Workshops and Congressional Testimony:

Friday, 6/17 – The Dermatologic and Ophthalmic Drugs Advisory Committee discusses aflibercept ophthalmic solution, proposed trade name EYLEA, for treatment of neovascular age-related macular degeneration (wet AMD). 8 a.m., The Inn & Conference Center, University of Maryland College, 3501 University Blvd. East, Adelphi, Md.

Press Office Contact: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov

FDA Office of Public Affairs Contact Information:

Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov

List of FDA press officers and beats

More Resources:

FDA News and Events

FDA Photos (Flickr)

Consumer Health Information

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading